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Background: A change of serum lactate concentrations appeared to be useful for predicting outcomes in various
acute ill settings. However, there is little information on intraoperative change of lactate level in pediatric cardiac
surgery patients.
Methods: We conducted a retrospective observational study of 459 children who received pediatric cardiac surgery
to determine the association between change of lactate level after cardiopulmonary bypass (CPB) and patient
prognosis (length of ICU stay and incidence of postoperative serious adverse events (SAEs)). We defined change of
lactate level after CPB (LAC⊿) as (final lactate level measurement in the operating room) – (lactate level measured
at the end of CPB). To study the independent association of LAC⊿ with length of ICU stay, we used linear
regression model.
Results: There were 1145 lactate measurements after CPB in this study cohort. After weaning from CPB, the serum
lactate levels significantly increased from 2.1 mmol/L to 2.5 mmol/L (p < 0.001). Patients with higher LAC⊿ had
significantly longer stay in ICU (p = 0.017) and higher incidence of SAEs (p = 0.002). In multivariate linear regression
analysis, higher LAC⊿ showed a significant independent association with longer length of ICU stay.
Conclusions: Increased lactate level after CPB was associated with the longer duration of ICU stay and increased
risk of postoperative SAEs in pediatric cardiac surgery patients. Future studies should be conducted to determine
the clinical utility of intraoperative trend of lactate levels.
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Hyperlactatemia observed in postoperative intensive care
unit were shown to have predictability for worse out-
comes in pediatric patients undergoing cardiac surgery
[1-6]. Early prediction of worse outcomes might be use-
ful to improve outcome by widening the therapeutic
time window or facilitating early intervention. In this
regards, it could be desired to assess whether intraopera-
tive lactate indices might have significant association
with postoperative worse outcomes in pediatric patients
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unless otherwise stated.The increase of blood lactate level would be caused by
increasing lactate production, decreasing lactate clear-
ance at liver, kidney and other organs, or both simultan-
eously [7]. The change of lactate concentration appears
to be useful for predicting outcomes in various acute ill
settings [8-14]. Furthermore, one study has suggested
that interventions aimed at targeting a lactate reduction
in the critically ill with an abnormal lactate level may re-
duce organ failure and increase survival [15]. However,
the change of lactate levels immediately following wean-
ing from cardiopulmonary bypass (CPB) and its associ-
ation with postoperative outcomes has been poorly
investigated in pediatric patients undergoing cardiac
surgery.ral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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change after CPB and patients’ outcome, we conducted
a retrospective observational study. We hypothesized
that larger change of lactate level after CPB would be as-
sociated with increased the duration of ICU stay and the
incidence of postoperative serious adverse events (SAEs)




This is a retrospective observational study, for which the
institutional review board of Okayama university waived
the need for obtaining informed consent and approved
its submission for publication.
Study population and data sources
This study was conducted in a tertiary teaching hospital
that had 865 beds in the hospital and 8 beds in the
pediatric cardiac ICU. We studied consecutive pediatric
patients who underwent pediatric cardiac surgery during
the period from January 1, 2007 to May 31, 2011. Inclu-
sion criteria for the current study were age <18 years,
undergone pediatric cardiac surgery that required CPB,
and with at least two lactate measurements after the end
of CPB.
Data on age, gender, the lowest temperature during
CPB and the duration of CPB were obtained from the
patients’ database, which had been prospectively col-
lected by trained physicians. Coding for type of surgery
was done by means of The Risk-Adjusted Classification
for Congenital Heart Surgery Version 1 (RACHS-1) cat-
egory [16]. We also obtained whether the patient re-
ceived epinephrine administration after CPB or not.
Lactate concentration measurements and lactate change
after CPB
All blood lactate concentrations were measured by an ar-
terial blood gas analyzer (ABL 800, Radiometer Co.,
Copenhagen, Denmark). The lactate data for this study
were corrected to a pH of 7.40. The lactate data reported
here were stored and retrieved electronically. Blood sam-
ples were collected in standard pre-prepared heparinized
blood gas syringes. The analyzer measured whole blood
samples at 37 degrees. Trained physicians performed all
blood gas analyses. Laboratory in the hospital complied
with standards of the National Association of Testing Au-
thorities. During the study period, arterial blood gas ana-
lyses were performed according to the decision of the
anesthetic specialist. Lactate ringer’s solution was not used
for fluid therapy during perioperative management.
We calculated delta lactate after CPB (LAC⊿) by the fol-
lowing: (last measurement of lactate level in the operatingroom(LacLast)) – (lactate level measured at the end of
CPB(LacFirst)).
Primary and secondary outcomes
Primary outcome was the duration of ICU stay. Second-
ary outcome was the incidence of at least one of SAEs.
We defined SAEs including cardiac arrest, the require-
ment of extracorporeal membrane oxygenation (ECMO),
and death during intensive care unit. All information
was prospectively collected by trained physicians and
stored electronically.
Statistical analysis
Data are presented as percentages (n) or as median (25%
quartile, 75% quartile). We first assessed the association
between LAC⊿ and the duration of ICU stay. Since its
relationship may not be linear in nature, we separated
patients into four subgroups according to each 1 mmol/L
of LAC⊿. This categorization was planned prior to ana-
lysis. We performed multivariate linear regression analysis
with adjustment for the following covariates: age, gender,
RACHS-1, the lowest temperature during CPB, the dur-
ation of CPB, the use of epinephrine after operation, the
duration between LacFIRST and LacLast, LacFirst and sub-
groups of LAC⊿. The dependent variable was the dur-
ation of ICU stay.
To assess the influence of the duration between LacFIRST
and LacLast, we further calculate the time weighted change
of lactate level after CPB (LAC⊿tw); LAC⊿divided by the
duration between LacFIRST and LacLast. We separated our
patients into 4 groups according to quartile of LAC⊿tw
(group1; 1st quartile, group2; 2nd quartile, group3; 3rd
quartile and 4th quartile; group4), and performed same
analysis with LAC⊿.
P values of less than 0.05 were considered statistically
significant. All statistical analyses were performed using
commercially available statistical software (SPSS 19.0,
SPSS Inc., Chicago, IL). Data was reported in accordance
with the Strengthening the Reporting of Observational
Studies in Epidemiology (STROBE) guidelines [17].
Results
Study flow
During study period, there were 459 pediatric patients
who received pediatric cardiac surgery required CPB and
had at least two lactate measurements after the end of
CPB. There was no patient with missing values.
Patients’ demographics and outcomes
Among study cohort, the median age was 14 months and
median RACHS-1 category was 3. The median CPB time
was 91 minutes. ICU stay in our cohort was a median of 6
days. There are 11 patients (2.4%) who had at least one
Table 2 The association of the duration of ICU stay with
delta change of lactate levels according to each 1 mmol/L
Delta change of
lactate levels
≦0 0-1 1-2 2< P-value
ICU stay median (IQR) 5 (3, 7) 5 (3, 8) 6 (3, 11) 6.5 (4, 13) 0.017
ICU; intensive care unit.
IQR; interquartile range.
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ECMO postoperatively and 7 patients died in ICU.
Lactate measurements after CPB
There were 1145 lactate measurements after CPB in this
study cohort. The median LAC⊿ was 0.3 mmol/L. After
weaning from CPB, the serum lactate levels were signifi-
cantly increased from 2.1 mmol/L to 2.5 mmol/L (p < 0.001)
(Table 1). The duration between LacFIRST and LacLast was
median of 62 minutes.
Univariate association of LAC⊿ with outcomes
Table 2 shows the duration of ICU stay among subgroups
according to LAC⊿. The population of each groups were
101 (LAC⊿≦0 mmol/L), 235 (LAC⊿ 0-1mmol/L), 86
(LAC⊿ 1-2mmol/L) and 37(LAC⊿ >2mmol/L).The dur-
ation of ICU stay significantly differed among subgroups
(p = 0.017) and increased according to increase of LAC⊿.
To assess the influence of age on this association, we
separated patients into two groups according to median
of ages and performed same analysis in both groups.
There was significant association between LAC⊿ and
length of ICU stay both in younger group (median of 3
months old, p < 0.001) and elder group (median of 3
years old , p = 0.016).
Figure 1 shows the incidence of SAEs among subgroups
according to LAC⊿. The incidence of SAEs significantly
differed among subgroups (p = 0.002) and increased when
LAC⊿ was >2 mmol/L.
Multivariate analysis
In our multivariate linear regression model including
possible confounders, LAC⊿ >2mmol/L was independentlyTable 1 Patient’s demographics
Variables median (IQR) or n(%)
Age (months old) 14 (3, 45)
Gender (male) 236/459(52.7%)
RACHS-1 3(2, 3)
Lowest temperature during CPB (°C) 32 (28,32)
CPB time, (min) 91 (66, 128)
The use of epinephrine after weaning from CPB 60/459 (13.1%)
ICU stay (day) 6 (3, 8)
The duration between LacFIRST and LacLast (min) 62 (37, 87)
LacFirst(mmol/L) 2.1 (1.3, 3.2)
LacLast (mmol/L) 2.5 (1.6, 3.8)
LAC⊿ (mmol/L) 0.3 (0, 1.0)
RACHS-1: Risk-Adjusted classification for Congenital Heart Surgery Version 1.
CPB: cardiopulmonary bypass.
ICU: intensive care unit.
LacFIRST: lactate level measured at the end of cardiopulmonary bypass.
LacLAST: lactate level measured at the end of operation.
LAC⊿: change of lactate levels after weaning from cardiopulmonary bypass.associated with increased the duration of ICU stay
(p = 0.028) (Table 3). In this analysis, LacFIRST was not
independently associated with the duration of ICU stay
(p = 0.41).
The time weighted change of lactate level after CPB
Length of ICU stay was significantly different among 4
groups according to the quartile of LAC⊿tw (p = 0.049).
The higher LAC⊿tw was associated with increased
length of ICU stay. We performed the another multivari-
ate linear regression model using subgroups of LAC⊿tw
(Table 4). Group 4 (the larger LAC⊿tw) was independ-
ently associated with increased the duration of ICU stay
(p = 0.048) (Table 4).
Discussion
Key finding
We performed a retrospective study to evaluate the use-
fulness of intraoperative lactate change after CPB for
predicting worse postoperative outcomes in pediatric
cardiac surgery patients. In our study, the duration of
ICU stay was significantly increased according to higher
LAC⊿. LAC⊿ >2 mmol/L was also associated with the
increased incidence of SAEs. Even after adjusting for
relevant confounders, LAC⊿ was independently associ-
ated with increased duration of ICU stay. This finding
was consisted even when we used the time weighted
change of lactate level after CPB.
Comparison with prior studies
While several studies have demonstrated that higher
blood lactate levels at weaning from CPB [18], chest
closure [18] and end of the operation [19,20], and max-
imum lactate level during the operation [21] were asso-
ciated with worse outcomes in pediatric cardiac surgery
patients, there has been a few report on the predictabil-
ity of intraoperative change of lactate concentration for
postoperative outcomes.
Munoz et al. have shown that increased lactate concen-
tration during CPB (defined as the difference between
baseline and the first lactate value obtained after CPB) was
associated with the risk of postoperative SAEs [1] in 174
pediatric cardiac surgery patients who required CPB. In
their multivariate logistic analysis, lactate change during
CPB tended to be independently associated with mortality



























Figure 1 The incidence of serious adverse events among subgroups according to each 1mmol/L of delta lactate levels after
cardiopulmonary bypass. This figure shows the incidence of serious adverse events among subgroups according to delta lactate levels after
cardiopulmonary bypass. The incidence of serious adverse events was significantly differed among subgroups (p = 0.002) and increased when
delta lactate level was >2 mmol/L in compared with those with >0 mmol/L.
Kanazawa et al. BMC Anesthesiology  (2015) 15:29 Page 4 of 6have shown that the lactate change from CPB weaning to
chest closure was significantly associated with major ad-
verse events [18]. However, they did not assess its inde-
pendent associations with patients’ outcomes.
To our knowledge, this is the first study to assess the in-
dependent predictability of intraoperative lactate change
after CPB for worse outcomes in pediatric cardiac surgeryTable 3 Multivariate analysis for duration of ICU stay
Coefficient p-value
Age (months old) 0.007 0.54
Gender (male) −0.4 0.85
RACHS-1 2.5 0.049
Lowest temperature during CPB (°C) −0.6 0.08
CPB time (min) 0.006 0.17
The use of epinephrine after weaning from CPB 15.1 <0.001
The duration between LacFIRST and LacLast (min) −0.24 0.65
LacFIRST (mmol/L) 0.7 0.42
LAC⊿≦0 mmol/L reference
LAC⊿ 0-1mmol/L (vs. LAC⊿≦0 mmol/L) 2.1 0.42
LAC⊿ 1-2mmol/L (vs. LAC⊿≦0 mmol/L) 0.8 0.81
LAC⊿ >2mmol/L (vs. LAC⊿≦0 mmol/L) 10.3 0.028
ICU: intensive care unit.
RACHS-1: Risk-Adjusted classification for Congenital Heart Surgery Version 1.
CPB: cardiopulmonary bypass.
LacFIRST: lactate level measured at the end of cardiopulmonary bypass.
LacLAST: last measurement of lactate level in the operating room.
LAC⊿:change of lactate level after cardiopulmonary bypass.patients. Although results did not conflict with the prior
study, further studies are required to confirm the clinical
utility of this measure.
Interpretation
It might be relevant to find biomarkers which can iden-
tify patients who are at higher risk of worse outcomes.Table 4 Multivariate analysis for duration of ICU stay
with the subgroups according to the interquartile of time
weighted delta lactate change
Coefficient p-value
Age (month) 0.01 0.39
Gender (male) 0.20 0.93
RACHS-1 1.75 0.19
Lowest temperature during CPB (°C) −0.33 0. 31
CPB time (min) 0.015 0. 55
The use of epinephrine after weaning from CPB 16.8 <0.001
LacFIRST (mmol/L) 1.17 0.17
Group1(1st quartile of LAC⊿tw) reference
Group2 (2nd quartile of LAC⊿tw) (vs. Group1) 2.60 0.39
Group3 (3rd quartile of LAC⊿tw) (vs. Group1) 0.16 0.96
Group4 (4th quartile of LAC⊿tw) (vs. Group1) 6.14 0.048
ICU: intensive care unit.
RACHS-1: Risk-Adjusted classification for Congenital Heart Surgery Version 1.
CPB: cardiopulmonary bypass.
LacFIRST: lactate level measured at the end of cardiopulmonary bypass.
LAC⊿tw: time weighted change of lactate level after cardiopulmonary bypass.
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to show that the significant association of the increase of
lactate concentration with increased risk of worse out-
comes in other settings [8-10,12,13], there were still few
studies to assess the association between intraoperative
lactate changes and outcomes in pediatric cardiac sur-
gery patients.
In compared with the lactate concentration in postop-
erative ICU, intraoperative lactate change had advantage
to promote the re-assess the quality of operation, cardiac
function, circulatory blood volume and ventilator setting
in operation room. This fact gives physicians the time
windows to early intervention including administration
of inotrope, adjustment of circulatory blood volume and
alternation of ventilator settings. We should note that
such an association existed even after adjusting the value
of LacFIRST and the duration between LacFIRST and LacLast.
This may suggest that irrespective of initial lactate value
after CPB and duration between measurements, the lac-
tate change after CPB was useful for prediction of worse
outcomes.
Limitation
Our study has several limitations. First, it is retrospective
in design and thus potentially subject to systematic error
and bias. However, the clinical and electronic data were
collected prospectively, are numerical in nature and
were measured independently, and were thus not amen-
able to unintended manipulation.
Second, the study was conducted in only one hospital.
The findings might be different for studies conducted in
other hospitals or in other countries with different styles
of management. However, it should be noted that there
has been no multicenter study in which the association of
lactate indices with outcomes in pediatric cardiac surgery
patients was assessed. A multicenter study should be con-
ducted in the future to refute or confirm our findings.
Third, there is no protocol for lactate measurements,
and the duration of post CPB (between end of CPB and
surgery) varied among patients. Such a time distribution
of LAC⊿ might affect our findings. However, we per-
formed multivariate analysis adjusting the duration be-
tween LacFIRST and LacLast and found that higher LAC⊿
had independent association with increased the length of
ICU stay. Furthermore, we calculated the time weighted
change of lactate level after CPB and also found that the
higher LAC⊿tw was independently associated with in-
creased length of ICU stay.
Fourth, in current study, we used pre-planed sub-
groups according to each 1 mmol/L of LAC⊿. Thus, our
study could not determine the threshold of LAC⊿ to
maximize its predictability of worse outcomes. Accord-
ingly, we performed post-hoc analysis to determine the
threshold of LAC⊿ to have larger area under the receiveroperator characteristic curve (AUROC curve). Then, we
found that LAC≧1.6mmol/L had largest AUROC curve
for the length of ICU stay and the incidence of SAEs
(Additional files 1 and 2). As this is post hoc analysis,
future study is necessary to address the threshold of intra-
operative change of lactate level for greater predictability
of postoperative outcomes.
Fifth, we included patients with wide range of age. As
age may influence the metabolic rate and oxygen tissue
oxygen requirements after surgery, the association with
LAC⊿ and patients’ outcomes may varied in different
ages. We found that there was significant association be-
tween LAC⊿ and length of ICU stay both in younger
and elder patients. Nonetheless, we believed that future
study is necessary to compare the magnitude of associ-
ation between LAC⊿ and outcomes among patients with
different ages.
Sixth, we included the 26 children required circulatory
arrest during surgery. This fact may influence our find-
ings. However, even after excluded these 26 patients, we
found that the duration of ICU stay significantly in-
creased according to each category of LAC⊿ (p = 0.017).
Finally, although we assessed the independent associ-
ation of LAC⊿ with outcomes with adjustment for age,
gender, lowest temp CPB, CPB time, RACHS-1 the dur-
ation between LacFIRST and LacLast and epinephrine use,
there may be other confounders that influenced the as-
sociation between LAC⊿ and outcomes. In this regards,
future study should be collected on these possible con-
founders to avoid potential biases.Conclusions
In conclusion, increased lactate concentration after CPB
was associated with risk of postoperative SAEs in pediatric
cardiac surgery patients. Future studies should be con-
ducted to confirm the potential utility of lactate change
after CPB as a future therapeutic target or trigger.Additional files
Additional file 1: This figure showed the area under the receiver
operator characteristic curve for the length of ICU stay in every
0.2mmol/L of LAC⊿. We found that largest the area under the receiver
operator characteristic curve was seen when the threshold was 1.6mmol/
L of LAC⊿.
Additional file 2: This figure showed the area under the receiver
operator characteristic curve for the incidence of postoperative
serious adverse events. The Maximum (sensitivity + specificity-1) was
see at LAC⊿ of 1.6mmol/L.
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